- Current report filing (8-K)
November 20 2009 - 8:41AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934
Date of Report
(Date of earliest event reported)
November 17, 2009
CANTEL
MEDICAL CORP.
(Exact name of
registrant as specified in its charter)
Delaware
|
|
001-31337
|
|
22-1760285
|
(State or other
jurisdiction
|
|
(Commission
|
|
(IRS
Identification
|
of
incorporation)
|
|
File Number)
|
|
Number)
|
150
Clove Road, Little Falls, New Jersey
|
|
07424
|
Address of
principal executive offices)
|
|
(Zip Code)
|
Registrants
telephone number, including area code:
(973) 890-7220
(Former name or
former address, if changed since last report)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425
under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01
Regulation FD Disclosure
Attached hereto as Exhibit 99.1
is an investor presentation of Cantel Medical Corp. (the Company), which may
be used in presentations by Company management to investors, analysts and
others from time to time, including a presentation to be made on November 20,
2009. The presentation will be posted on
the Companys website, www.cantelmedical.com. The information included in Exhibit 99.1
shall not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or incorporated by reference in any filing
under the Securities Act of 1933, as amended.
Item 9.01 Financial Statements
and Exhibits
(d) Exhibits
99.1 Cantel Medical Corp.
Investor Presentation November 17, 2009
2
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly
authorized.
|
|
CANTEL MEDICAL CORP.
|
|
|
|
|
|
|
|
|
By:
|
/s/ Andrew A. Krakauer
|
|
|
|
Andrew A. Krakauer
|
|
|
|
President
|
Dated: November 17, 2009
3
Exhibit Index
Exhibit No.
|
|
Exhibit Description
|
|
|
|
99.1
|
|
Cantel Medical Corp.
Investor Presentation November 17, 2009
|
4
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cantel Medical (NYSE:CMD)
Historical Stock Chart
From Jul 2023 to Jul 2024